Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues

References

• Vogt A, Schmid S, Heinimann K, et al. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2):e000172. doi:10.1136/esmoopen-2017-00017228761745
   PubMed Web of Science ®Google Scholar
• Travis LB, Demark Wahnefried W, Allan JM, Wood ME, Ng AK. Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors. Nat Rev Clin Oncol. 2013;10(5):289–301. doi:10.1038/nrclinonc.2013.4123529000
   PubMed Web of Science ®Google Scholar
• Travis LB, Rabkin CS, Brown LM, et al. Cancer survivorship–genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006;98:15–25. doi:10.1093/jnci/djj00116391368
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Zheng G, Hemminki O, Forsti A, Sundquist K, Hemminki K. Prostate cancer survivors: risk and mortality in second primary cancers. Cancer Med. 2018;7(11):5752–5759. doi:10.1002/cam4.176430277023
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Hemminki A, Försti A, Sundquist K, Sundquist J, Hemmiinki K. Familial risks and mortality in second primary cancers in melanoma. JNCI Cancer Spectr. 2019;2:pky068. doi:10.1093/jncics/pky06831360883
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Hemminki O, Forsti A, Sundquist K, Sundquist J, Hemminki K. Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer. Prostate Cancer Prostatic Dis. 2018.
   Google Scholar
• Centre for Epidemiology. Cancer Incidence in Sweden 2012. Stockholm: The National Board of Health and Welfare; 2013.
   Google Scholar
• Green AC, Olsen CM. Cutaneous squamous cell carcinoma: an epidemiological review. Br J Dermatol. 2017;177(2):373–381. doi:10.1111/bjd.1532428211039
   PubMed Web of Science ®Google Scholar
• IARC. Personal Habits and Indoor Combustions, Vol. 100E. Lyon: International Agency for Research on Cancer; 2012:575.
   Google Scholar
• Omland SH, Ahlstrom MG, Gerstoft J, et al. Risk of skin cancer in patients with HIV: a Danish nationwide cohort study. J Am Acad Dermatol. 2018;79(4):689–695. doi:10.1016/j.jaad.2018.03.02429588249
   PubMed Web of Science ®Google Scholar
• Hortlund M, Arroyo Muhr LS, Storm H, Engholm G, Dillner J, Bzhalava D. Cancer risks after solid organ transplantation and after long-term dialysis. Int J Cancer. 2017;140(5):1091–1101. doi:10.1002/ijc.3053127870055
   PubMed Web of Science ®Google Scholar
• Harwood CA, Toland AE, Proby CM, et al. The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients. Br J Dermatol. 2017;177(5):1217–1224. doi:10.1111/bjd.1595629086420
   PubMed Web of Science ®Google Scholar
• Bottomley MJ, Thomson J, Harwood C, Leigh I. The role of the immune system in cutaneous squamous cell carcinoma. Int J Mol Sci. 2019;20(8):2009. doi:10.3390/ijms20082009
   Web of Science ®Google Scholar
• Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among death registry, cancer registry and hospital discharge registry. Int J Cancer. 2012;131:2085–2093. doi:10.1002/ijc.2746222307919
   PubMed Web of Science ®Google Scholar
• Pukkala E, Engholm G, Hojsgaard Schmidt LK, et al. Nordic cancer registries - an overview of their procedures and data comparability. Acta Oncol. 2018;57:440–455. doi:10.1080/0284186X.2017.140703929226751
   PubMed Web of Science ®Google Scholar
• Chen T, Fallah M, Brenner H, et al. Risk of second primary cancers in multiple myeloma survivors in german and swedish cancer registries. Sci Rep. 2016;6:22084. doi:10.1038/srep2208426908235
   PubMed Web of Science ®Google Scholar
• Chen T, Fallah M, Jansen L, et al. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer Lett. 2015;369(1):152–166. doi:10.1016/j.canlet.2015.08.01426319898
   PubMed Web of Science ®Google Scholar
• Chattopadhyay S, Hemminki A, Forsti A, Sundquist K, Sundquist J, Hemminki K. Second primary cancers in patients with invasive and in situ squamous cell skin carcinoma, Kaposi sarcoma and Merkel cell carcinoma: role for immune mechanisms? J Invest Dermatol. 2019.
   Google Scholar
• Chattopadhyay S, Sud A, Zheng G, et al. Second primary cancers in non-Hodgkin lymphoma: bi-directional analyses suggesting role for immune dysfunction. Int J Cancer. 2018;143:2449–2457. doi:10.1002/ijc.3180130238973
   PubMed Web of Science ®Google Scholar
• Hemminki K, Hemminki O, Försti A, Sundquist K, Sundquist J, Li X. Surveillance bias in cancer risk after unrelated medical conditions: example urolithiasis. Sci Rep. 2017;7:8073. doi:10.1038/s41598-017-08839-528808281
   PubMed Web of Science ®Google Scholar
• Emens LA, Ascierto PA, Darcy PK, et al. Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape. Eur J Cancer. 2017;81:116–129. doi:10.1016/j.ejca.2017.01.03528623775
   PubMed Web of Science ®Google Scholar
• Rama I, Grinyo JM. Malignancy after renal transplantation: the role of immunosuppression. Nat Rev Nephrol. 2010;6(9):511–519. doi:10.1038/nrneph.2010.10220736984
   PubMed Web of Science ®Google Scholar
• Harms PW, Harms KL, Moore PS, et al. The biology and treatment of Merkel cell carcinoma: current understanding and research priorities. Nat Rev Clin Oncol. 2018;15(12):763–776. doi:10.1038/s41571-018-0103-230287935
   PubMed Web of Science ®Google Scholar
• Rangwala S, Tsai KY. Roles of the immune system in skin cancer. Br J Dermatol. 2011;165(5):953–965. doi:10.1111/j.1365-2133.2011.10507.x21729024
   PubMed Web of Science ®Google Scholar
• Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392:1–10. doi:10.1016/j.virol.2009.06.00119720205
   PubMed Web of Science ®Google Scholar
• IARC. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt B):1–441.
   Google Scholar